Rare-Event Analysis in Flow Cytometry

Clinics in Laboratory Medicine

Volumn 27, Issue 3, 2007, Pages 627-652

  Donnenberg, Albert D ^a   Donnenberg, Vera S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ASSAY; CELL POPULATION; CELLULAR PARAMETERS; CLINICAL LABORATORY; FLOW CYTOMETRY; HUMAN; INCIDENCE; MEDICAL RESEARCH; PHENOTYPE; PRIORITY JOURNAL; RARE EVENT ANALYSIS; REPRODUCIBILITY; REVIEW; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS;

FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34447523459     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2007.05.013     Document Type: Review

References (61)

1. Gross H.J., Verwer B., Houck D., et al. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc Natl Acad Sci U S A 92 2 (1995) 537-541
2. van den Engh G. New applications of flow cytometry. Curr Opin Biotechnol 4 1 (1993) 63-68
3. Rosenblatt J.I., Hokanson J.A., McLaughlin S.R., et al. Theoretical basis for sampling statistics useful for detecting and isolating rare cells using flow cytometry and cell sorting. Cytometry 27 3 (1997) 233-238
4. Donnenberg A.D., and Meyer E.M. Principles of rare event analysis by flow cytometry: detection of injected dendritic cells in draining lymphatic tissue. Clinical Immunology Newsletter 19 10-11 (1999) 124-128
5. Baumgarth N., and Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 243 1-2 (2000) 77-97
6. Donnenberg V.S., and Donnenberg A.D. Identification, rare-event detection and analysis of dendritic cell subsets in broncho-alveolar lavage fluid and peripheral blood by flow cytometry. Front Biosci 8 (2003) s1175-s1180
7. Altman J.D., Moss P.A.H., Goulder P.R., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
8. NIH Tetramer Core Facility at Emory University. Available at: http://research.yerkes.emory.edu/tetramer_core/index.html. Accessed June 18, 2007.
9. Maino V.C., and Picker L.J. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 34 5 (1998) 207-215
10. Listman J.A., Wang Y., Castro J.E., et al. Detection of rare apoptotic T cells in vivo. Cytometry 33 3 (1998) 340-347
11. Muraro P.A., Jacobsen M., Necker A., et al. Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 246 1-2 (2000) 131-143
12. Walle A.J., and Niedermayer W. Aneuploidy as a marker of minimal residual disease in leukemia. Cancer Detect Prev 8 1-2 (1985) 303-315
13. Ryan D.H., Mitchell S.J., Hennessy L.A., et al. Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry. J Immunol Methods 74 1 (1984) 115-128
14. Hussain M., Kukuruga M., Biggar S., et al. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases. Cytometry 26 1 (1996) 40-46
15. Balic M., Dandachi N., Hofmann G., et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68 1 (2005) 25-30
16. Allard W.J., Matera J., Miller M.C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10 20 (2004) 6897-6904
17. Dick J.E. Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 100 7 (2003) 3547-3549
18. Donnenberg V.S., and Donnenberg A.D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45 8 (2005) 872-877
19. Donnenberg VS, Luketich JD, Landreneau RJ, et al. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Res Found Workshop, in press.
20. Donnenberg VS, Landreneau RJ, Donnenberg AD. Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release, in press.
21. Al-Hajj M., Wicha M.S., Benito-Hernandez A., et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 7 (2003) 3983-3988
22. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 7015 (2004) 396-401
23. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A 103 30 (2006) 11154-11159
24. Goodell M.A., Brose K., Paradis G., et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183 4 (1996) 1797-1806
25. Zhou S., Schuetz J.D., Bunting K.D., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7 9 (2001) 1028-1034
26. Muller C., Bonmann M., Cassens U., et al. Flow cytometric analysis of protein phosphorylation in the hematopoetic system. Leuk Lymphoma 29 3-4 (1998) 351-360
27. Rosu-Myles M., Khandaker M., Wu D.M., et al. Characterization of chemokine receptors expressed in primitive blood cells during human hematopoietic ontogeny. Stem Cells 18 5 (2000) 374-381
28. Henon P.H., Sovalat H., and Bourderont D. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment. J Biol Regul Homeost Agents 15 1 (2001) 62-67
29. Pratt G., Rawstron A.C., English A.E., et al. Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve. Br J Haematol 114 4 (2001) 937-943
30. Shapiro R., Rao A.S., Fontes P., et al. Combined simultaneous kidney/bone marrow transplantation. Transplantation 60 12 (1995) 1421-1425
31. Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leuk Res 31 4 (2007) 439-444
32. Jones E.A., English A., Kinsey S.E., et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 70 6 (2006) 391-399
33. George F., Brisson C., Poncelet P., et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost 67 1 (1992) 147-153
34. Bohmer R.M., Zhen D., and Bianchi D.W. Identification of fetal nucleated red cells in co-cultures from fetal and adult peripheral blood: differential effects of serum on fetal and adult erythropoiesis. Prenat Diagn 19 7 (1999) 628-636
35. Geifman-Holtzman O., Makhlouf F., Kaufman L., et al. The clinical utility of fetal cell sorting to determine prenatally fetal E/e or e/e Rh genotype from peripheral maternal blood. Am J Obstet Gynecol 183 2 (2000) 462-468
36. Bajaj S., Welsh J.B., Leif R.C., et al. Ultra-rare-event detection performance of a custom scanning cytometer on a model preparation of fetal nRBCs. Cytometry 39 4 (2000) 285-294
37. Bianchi D.W., Zickwolf G.K., Weil G.J., et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93 2 (1996) 705-708
38. Qu L., Triulzi D.J., Rowe D.T., et al. Stability of Lymphocytes and EBV during RBC Storage. Vox Sanguinis 92 (2007) 125-129
39. Garritsen H.S., and Sibrowski W. Flow cytometric determination of leukocytes and lymphocyte subsets in thrombocytapheresis products. Beitr Infusionsther Transfusionsmed 32 (1994) 401-404
40. Triulzi D.J., Meyer E.M., and Donnenberg A.D. WBC subset analysis of WBC-reduced platelet components. Transfusion 40 7 (2000) 771-780
41. Barrat-Boyes S.M., Zimmer M.I., Harshyne L.A., et al. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol 164 (2000) 2487-2495
42. Parish C.R. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol 77 6 (1999) 499-508
43. Donnenberg V.S., O'Connell P.J., Logar A.J., et al. Rare event analysis of circulating human dendritic cell subsets and their presumptive mouse counterparts. Transplantation 72 12 (2001) 1946-1951
44. McIlroy D., Troadec C., Grassi F., et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood 97 11 (2001) 3470-3477
45. Morelli A.E., Hackstein H., and Thomson A.W. Potential of tolerogenic dendritic cells for transplantation. Semin Immunol 13 5 (2001) 323-335
46. Fong L., Brockstedt D., Benike C., et al. Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 166 6 (2001) 4254-4259
47. Kuwana M., Kaburaki J., Wright T.M., et al. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 31 9 (2001) 2547-2557
48. Liau S., Yancovitz S.R., Qureshi M.N., et al. The number of CD1a+ large low-density cells with dendritic cell features is increased in the peripheral blood of HIV+ patients. Clin Immunol Immunopathol 70 3 (1994) 190-197
49. Kramer B., Grobusch M.P., Suttorp N., et al. Relative frequency of malaria pigment-carrying monocytes of nonimmune and semi-immune patients from flow cytometric depolarized side scatter. Cytometry 45 2 (2001) 133-140
50. Medina F., Segundo C., and Brieva J.A. Purification of human tonsil plasma cells: pre-enrichment step by immunomagnetic selection of CD31(+) cells. Cytometry 39 3 (2000) 231-234
51. Rehse M.A., Corpuz S., Heimfeld S., et al. Use of fluorescence threshold triggering and high-speed flow cytometry for rare event detection. Cytometry 22 4 (1995) 317-322
52. Shapiro H.M. Practical flow cytometry. 4th edition (2003), John Wiley and Sons, Hoboken (NJ)
53. Cupp J.E., Leary J.F., Cernichiari E., et al. Rare-event analysis methods for detection of fetal red blood cells in maternal blood. Cytometry 5 2 (1984) 138-144
54. Owens M., and Loken M.R. Flow cytometry principles for clinical laboratory practice: quality assurance for quantitative immunophenotyping (1995), Wylie-Liss, New York p. 111-28
55. Aubin J.E. Autofluorescence of viable cultured mammalian cells. J Histochem Cytochem 27 1 (1979) 36-43
56. Hoffmann T.K., Donnenberg V.S., Friebe-Hoffmann U., et al. Rapid communication: competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the tcr complex. Cytometry 41 (2000) 321-328
57. Telford W., Murga M., Hawley T., et al. DPSS yellow-green 561-nm lasers for improved fluorochrome detection by flow cytometry. Cytometry A 68 1 (2005) 36-44
58. Gross H.J., Verwer B., Houck D., et al. Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14 5 (1993) 519-526
59. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45 3 (2001) 194-205
60. Sutherland D.R., Anderson L., Keeney M., et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5 3 (1996) 213-226
61. June C.H., Ledbetter J.A., Rabinovitch P.S., et al. Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J Clin Invest 77 4 (1986) 1224-1232